Traditional Friedewald LDL-C Calculator
Reproduce the traditional 1972 Friedewald LDL-C estimate from one same-unit lipid panel, with exact triglyceride boundaries and current-method limitations.
Content updated: View sources
QuickMedCalc is developed and maintained by an independent developer. Medical content is not independently reviewed by a physician.
Formula and medical content are based on the references listed on this page. See sources, About, and Sources and Review Process.
Model identity: this page reproduces only the traditional 1972 Friedewald LDL-C equation after one complete, same-unit lipid panel is submitted. It does not calculate Martin/Hopkins or Sampson/NIH LDL-C, identify the method on a laboratory report, classify the result, or determine a goal or treatment.
About
This page is a Traditional 1972 Friedewald LDL-C Calculator. It uses total cholesterol, HDL-C, and triglycerides from one same-unit lipid panel and reports non-HDL-C, an estimated VLDL-C term, and the historical Friedewald LDL-C estimate. It does not directly measure LDL-C, identify the laboratory method, calculate ASCVD risk, set an LDL-C goal, or choose treatment. [1, 6]
The original study used 448 fasting plasma samples and treated triglycerides divided by 5 as an estimated VLDL-C term, not a measured VLDL-C concentration. The fixed ratio is a historical model assumption; chylomicrons, abnormal VLDL composition, type III dysbetalipoproteinemia, and changing triglyceride composition can make it less representative.[1, 2]
Current guidance prefers modern LDL-C estimation methods for a standard lipid profile in appropriate settings, but this page deliberately does not replace its frozen Friedewald runtime. Martin/Hopkins, extended Martin/Hopkins, Sampson/NIH, direct homogeneous assays, and beta-quantification are different methods and are not silently inferred from this result. [3, 4, 6, 7, 10, 11]
Formula
Interpretation
LDL-C method comparison
| Method | What it does | This page |
|---|---|---|
| Traditional Friedewald [1] | Fixed TG divisor of 5 in mg/dL or 2.2 in mmol/L. | The only runtime model; TG must be below this page's boundary. |
| Martin/Hopkins or extended Martin/Hopkins [3, 5] | Uses an adjustable TG:VLDL-C factor based on TG and non-HDL-C strata. | Described as a modern alternative, never calculated here. |
| Sampson/NIH [4] | A distinct nonlinear equation developed and validated against beta-quantification references, including higher-TG research settings. | Not calculated here; its range is not imported into Friedewald validation. |
| Direct homogeneous LDL-C assay [6, 7] | An automated measurement method whose platform, reagents, calibration, low LDL-C, high TG, and unusual lipoproteins can affect comparability. | No direct measurement is performed. |
| Beta-quantification [4, 6] | A reference measurement path involving ultracentrifugation and subsequent fraction analysis; it is not the same as a routine direct homogeneous assay. | Not executed here. |
Why current practice may use another method
The fixed TG:VLDL-C ratio can vary with triglyceride level, non-HDL-C, lipoprotein composition, and low LDL-C. Studies comparing Friedewald with direct or preparative-ultracentrifugation references found method differences that can matter near clinical decision thresholds, without creating a personal correction that this calculator can apply.[2, 5]
The 2026 ACC/AHA guideline prefers Martin/Hopkins or Sampson/NIH over Friedewald for LDL-C estimation from a standard lipid profile, and ADLM guidance emphasizes reporting the actual calculated, direct, or beta-quantification method. The two formal corrections are kept as separate references; this page does not automatically replace the user's selected historical equation. [6, 7, 10, 11]
Fasting, nonfasting, and the triglyceride boundary
The original Friedewald work used fasting plasma data. Modern standard lipid profiles commonly allow fasting or nonfasting collection, but food and other pre-analytic conditions can change triglycerides and therefore affect a fixed-divisor estimate. Certain high-TG or other clinical contexts may call for a fasting repeat; this page neither collects fasting status nor declares a sample valid or invalid.[1, 6, 9]
The runtime boundary is strictly TG <400 mg/dL or <4.5 mmol/L. Being below it permits only the arithmetic and does not guarantee accuracy. At or above it, the model is withheld rather than extended to the higher-TG research range of Sampson/NIH or another method.[1, 4, 6]
What the reported quantities do and do not mean
LDL-C is cholesterol mass estimated within LDL particles; it is not LDL particle number or ApoB. ApoB reflects particle-containing lipoproteins, and one particle can carry different cholesterol amounts, so the measures can be discordant. Non-HDL-C is TC − HDL-C and includes cholesterol in multiple non-HDL lipoprotein classes. Lp(a)-cholesterol can contribute to lipid measurements, but this page does not separate Lp(a)-C or infer ApoB, LDL-P, or Lp(a) from any displayed card.[6, 8]
The estimated VLDL-C term is TG divided by the selected historical divisor, not a measured VLDL-C result. If the submitted arithmetic is zero or negative, the page withholds the estimate instead of clamping it to zero or presenting a negative cholesterol concentration. ADLM guidance supports appropriate lower reporting limits; this behavior is a display-safety and model-compatibility boundary, not a diagnosis.[1, 6, 7]
Clinical contexts not modeled here
Pregnancy, pediatric lipid assessment, familial hypercholesterolemia, familial chylomicronemia, type III dysbetalipoproteinemia, severe hypertriglyceridemia, cholestatic liver disease or LpX, acute illness, diabetes, kidney disease, lipid-lowering therapy, very low LDL-C, and unusual lipoprotein composition may affect method choice or interpretation. This page does not diagnose those conditions, assign normal or abnormal categories, set a personal target, or recommend a medicine or dose. [6, 8, 10]
How to use this page without changing the model
Choose the unit printed for the panel, enter TC, HDL-C, and TG from the same report, and submit explicitly. A unit change clears the numeric fields rather than silently converting them. The result cards expose the subtraction and fixed-divisor term so that a later laboratory comparison can retain the method identity.[1, 6]
Why a laboratory method name matters
A report may identify calculated LDL-C, direct homogeneous LDL-C, or a reference procedure. Those labels describe different measurement or estimation paths. Keep the laboratory's stated method when comparing serial values, and do not treat this historical calculator as a way to reconstruct a missing assay result. [5, 6, 7]
Why this page has no LDL-C target
Contemporary LDL-C and non-HDL-C targets depend on the prevention and disease pathway, overall risk, and clinical history. The four values accepted here cannot establish those conditions, so the page reports transparent arithmetic without a goal, diagnosis, or treatment output.[10, 11]
References
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. PMID 4337382.
- Martin SS, Blaha MJ, Elshazly MB, et al. Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. J Am Coll Cardiol. 2013;62(8):732–739. PMID 23524048. DOI 10.1016/j.jacc.2013.01.079.
- Martin SS, Blaha MJ, Elshazly MB, et al. Comparison of a novel method vs the Friedewald equation for estimating LDL-C levels from the standard lipid profile. JAMA. 2013;310(19):2061–2068. PMID 24240933. DOI 10.1001/jama.2013.280532.
- Sampson M, Ling C, Sun Q, et al. A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540–548. PMID 32101259. PMCID PMC7240357. DOI 10.1001/jamacardio.2020.0013.
- Martin SS, Giugliano RP, Murphy SA, et al. Comparison of LDL-C Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial. JAMA Cardiol. 2018;3(8):749–753. PMID 29898218. DOI 10.1001/jamacardio.2018.1533.
- Cao J, Donato L, El-Khoury JM, et al. ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins. J Appl Lab Med. 2024;9:1040–1056. PMID 39225455. DOI 10.1093/jalm/jfae057.
- Correction to: ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins. J Appl Lab Med. 2025;10(4):1085. PMID 40172951. DOI 10.1093/jalm/jfaf021.
- Langlois MR, Nordestgaard BG, Langsted A, et al. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM. Clin Chem Lab Med. 2020;58(4):496–517. PMID 31855562. DOI 10.1515/cclm-2019-1253.
- Nordestgaard BG, Langsted A, Mora S, et al. Fasting Is Not Routinely Required for Determination of a Lipid Profile. Clin Chem. 2016;62(7):930–946. PMID 27235445. DOI 10.1373/clinchem.2016.258897.
- Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. Circulation. 2026;153:e1154–e1276. PMID 41824552. DOI 10.1161/CIR.0000000000001423.
- Correction to: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. Circulation. 2026;153(25):e1447. PMID 42330109. DOI 10.1161/CIR.0000000000001457.
FAQ
LDL-C = total cholesterol − HDL-C − (triglycerides ÷ 5), with all three submitted measurements in mg/dL. The triglyceride-divisor term is a traditional estimate of VLDL-C, not a measured VLDL-C value.
Sources: [1]
LDL-C = total cholesterol − HDL-C − (triglycerides ÷ 2.2), with all three submitted measurements in mmol/L. The page does not convert a mixed-unit panel or use the mg/dL divisor in SI units.
Sources: [1]
The original method used a fixed triglyceride-to-VLDL-cholesterol relationship: 5 when concentrations are expressed in mg/dL and 2.2 in mmol/L. That relationship varies between samples and people, which is an important limitation of the estimate.
Sources: [1]
No. Total cholesterol, HDL-C and triglycerides must come from the same specimen and use the one selected unit. Changing the unit clears every value so an old number cannot be reinterpreted silently.
Sources: [1]
The original 1972 Friedewald relationship was derived from fasting plasma data and depends on a fixed triglyceride-to-VLDL-C ratio. Modern guidance allows fasting or nonfasting standard lipid profiles for many people and prefers Martin/Hopkins or Sampson/NIH for estimated LDL-C. The fixed historical assumption may not hold with triglyceride metabolism abnormalities, chylomicrons, type III dysbetalipoproteinemia, or clearly high triglycerides. This page cannot identify whether a sample was truly fasting, contains chylomicrons, has type III dysbetalipoproteinemia or unusual VLDL composition, or which LDL-C method the laboratory used. Being below 400 mg/dL or 4.5 mmol/L only permits this historical arithmetic; it does not prove that the estimate is accurate or applicable to the sample.
Related Calculators
Non-HDL-C
Calculate non-HDL cholesterol from total cholesterol minus HDL-C from the same lipid panel, with unit-safe arithmetic and guideline-context limitations.
TC/HDL Ratio
Calculate the unitless total cholesterol-to-HDL-C ratio from one same-panel lipid profile, with exact arithmetic and current-guideline limitations.
Unit Converter
Convert 10 common serum and plasma laboratory values between conventional and SI reporting units using analyte-specific factors.
Disclaimer
Educational and informational reference only. Not intended to replace professional medical advice, diagnosis, treatment, or independent verification.